Thank you. Listen to this article using the player above. ✖
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Dr. Evrony’s research, performed at Boston Children's Hospital and Harvard
Medical School with Dr. Christopher Walsh and colleagues, has revealed a
diversity of mutations in neuronal genomes indicating that every neuron in
the brain carries a unique fingerprint of somatic mutations. Such mutations
can cause focal brain malformations and may have a role in other unsolved
neurologic diseases. The technology also allows, for the first time,
reconstruction of developmental lineage trees in the human brain to study
how cells proliferate and migrate to build the brain.
Gilad Evrony received his undergraduate degree from the Massachusetts
Institute of Technology. He served in the Intelligence Division of the Israel
Defense Forces and completed an M.D. and Ph.D. at Harvard Medical School,
with graduate research in the laboratory of Dr. Christopher Walsh at Boston
Children's Hospital. Dr. Evrony is currently pursuing clinical training in
pediatrics at Mount Sinai Hospital in New York and continuing his research
developing novel technologies for studying the brain and neuropsychiatric
The annual US$25,000 Eppendorf & Science Prize for Neurobiology honors
scientists, like Dr. Evrony, for their ground-breaking research. Gilad Evrony
is the 15th recipient of this international award which is awarded jointly by
Eppendorf and the journal Science. Researchers who are not older than 35
years and have made outstanding contributions to neurobiological research
based on methods of molecular and cell biology are invited to apply. The
next deadline for applications is June 15, 2017.